Coalition against Typhoid Director Imran Khan and Senior Technical Officer Stacy Davlin both presented at the The Indonesian Technical Advisory Group on Immunizations Conference on April 27, 2015 in Jakarta, Indonesia. The ITAGI hosted the conference on the global burden of typhoid and the agenda to develop a typhoid conjugate vaccine.
Every year, typhoid fever results in thousands of deaths worldwide. Though typhoid is treatable with antibiotics, resistance to commonly used antibiotics is a widespread problem. In addition, a lack of effective diagnostic tests results in delayed or inaccurate treatment. Together, these problems underscore the need for widespread typhoid vaccine use. However, access to typhoid vaccines remains low in many high burden areas including Indonesia.
Presentations
Global Burden of Typhoid Fever
Imran Khan, Coalition against Typhoid, Washington, DC
Surveillance on Enteric Fever in Asia Project
Stacy Davlin, Coalition against Typhoid, Washington DC
Typhoid Control Program in Indonesia
Naning Nugrahini, CDC-EH, Indonesia
Typhoid Profile on National Basic Health Research (RISKESDAS) 2007
Magdarina D. Agtini, NIHRD, Indonesia
Update on Typhoid Fever Clinical Management and Drug Susceptibility in Children
Mulya Rahma Karyanti, University of Indonesia, Jakarta, Indonesia
Salmonella enterica var Typhi: Blood Culture & Epidemiological Study
Lenny Ekawati and Decy Subekti, Eijkman-Oxford Clinical Research Unit, Jakarta, Indonesia
Development of Typhoid Conjugate Vaccine in Bio Farma
Erman Tritama, Bio Farma, Indonesia
New Vaccine Regulatory Framework in Indonesia
Nurma Hidayati, National Agency of Drug and Food Control, The Republic of Indonesia
